News
Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.
A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...
Scientists at the Allen Institute have made a major breakthrough in research for people living with Dravet Syndrome, which is a rare and debilitating form of epilepsy that starts within the first ...
Tesla (T) magnetic resonance imaging (MRI) changes management in more than half of adult candidates for epilepsy surgery.
Healthcare Asia Magazine on MSN1d
The Alfred introduces laser technology for epilepsy surgeryThe MRI-guided technique allows surgeons to access deeper brain regions. Australia’s The Alfred is the first hospital in Victoria to introduce laser interstitial thermal therapy for epilepsy surgery.
For families dealing with childhood epilepsy, these neural disruptions ... to give their child appropriate independence. Family therapy specifically experienced with chronic childhood conditions ...
Proceeds from the financing will be used to advance the company’s wholly owned pipeline of allogeneic cell therapy candidates ... mesial temporal lobe epilepsy (MTLE), which is among the most ...
Mar. 25, 2025 — A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers. If the drug proves viable for human ...
follows continued positive clinical signal from Neurona's ongoing Phase 1/2 clinical trial - The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy ...
Mayo Clinic is taking epilepsy research in a bold new direction, exploring treatment approaches to help patients living with the most severe and difficult-to-treat forms of epilepsy. About 50 million ...
A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results